title: A Chinese girl with novel PLCE1 mutations and proliferation of the mesangium responded to tacrolimus therapy.
authors.affiliation: Department of Nephrology, Capital Institute of Pediatrics, Beijing, China.
authors.forename: Tiantian
authors.initials: T
authors.lastname: Lin
authors.forename: Jianguo
authors.initials: J
authors.lastname: Li
authors.forename: Fenghua
authors.initials: F
authors.lastname: Wang
authors.forename: Li
authors.initials: L
authors.lastname: Cao
authors.forename: Jianxin
authors.initials: J
authors.lastname: Wu
authors.forename: Juan
authors.initials: J
authors.lastname: Tu
authors.forename: Lina
authors.initials: L
authors.lastname: Ji
authors.forename: Haiyun
authors.initials: H
authors.lastname: Geng
authors.forename: Chaoying
authors.initials: C
authors.lastname: Chen
authors.forename: Dakun
authors.initials: D
authors.lastname: Chen
mesh_terms: D049109:Cell Proliferation; D002675:Child, Preschool; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D005920:Glomerular Mesangium / Q000473:pathology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D020125:Mutation, Missense; D054801:Phosphoinositide Phospholipase C / Q000235:genetics*; D016559:Tacrolimus / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D054801:Phosphoinositide Phospholipase C; C423320:phospholipase C epsilon; D016559:Tacrolimus